Skip to main content
24 November 2024
Last updated:
Friday 22 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Policy & Regulation
Policy & Regulation
EMA launches consultation on AI
Read more
FDA draft guidance on psychedelics
Read more
Commentary: FDA guides industry on psychedelic drugs
Read more
US selects first drugs for price negotiations
Read more
The EMA reviews the use of real-world evidence
Read more
Strengths and shortcomings of new EU rules for ATMPs
Read more
EU regulators agree Covid-19 vaccine strategy
Read more
Step up the fight against superbugs, says EU
Read more
European Commission highlights access, supply in pharma proposal
Read more
FDA guides on accelerated approvals in oncology
Read more
Pagination
Previous page
‹‹
Page 2
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form